The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The burden of neuropathic pain: results from a cross‐sectional survey
Abstract
Background There are few published data on the treatment patterns and burden of neuropathic pain. We have investigated this in a large, observational, cross‐sectional survey. Methods We surveyed 602 patients with neuropathic pain recruited from general practitioners in six European countries. Physicians recorded demographic and treatment information, including prescription medications. Patients completed Brief Pain Inventory (BPI) severity and interference questions, the EuroQol (EQ‐5D), and questions about their productivity, non‐prescription treatments, and frequency of physician visits. The BPI Pain Severity score (range: 0–10) is the mean of worst, least, average, and current pain ratings, with scores of 4–6 and 7–10 considered moderate and severe, respectively. We evaluated the impact of pain severity on functioning using analysis of variance models and χ 2 tests. Results Mean (SD) age was 62.9 (14.4) years (50% female). Most patients reported moderate (54%) or severe (25%) pain. Nearly all patients (93%) were prescribed medications for their neuropathic pain: analgesics (71%); anti‐epileptics (51%); antidepressants (29%); sedatives/hypnotics (15%). Seventy‐six percent visited their physician at least once in the past month. Employment status was affected in 43% of patients; those employed missed a mean (SD) of 5.5 (9.8) workdays during the past month. Pain severity was associated significantly (P < 0.001) with poorer EQ‐5D scores (mild = 0.67, moderate = 0.46, severe = 0.16), greater disruption of employment status (mild = 24%, moderate = 48%, severe = 54%), and more frequent physician visits (% with one or more visits: mild = 66%, moderate = 79%, severe = 83%). Conclusions Patients with neuropathic pain visit their physician frequently and report substantial pain that interferes with daily functioning despite receiving treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
EuroQol: the current state of play
Brooks, R. (1996) · Health Policy · doi:10.1016/0168-8510(96)00822-6 · Cited by 5,815
Pain assessment: global use of the Brief Pain Inventory.
Cs, C., & Km, R. (1994) · PubMed · Cited by 5,421
(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544
Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases
Daut, R. L., Cleeland, C. S., & Flanery, R. C. (1983) · Pain · doi:10.1016/0304-3959(83)90143-4 · Cited by 1,562
Backonja, M. (1998) · JAMA · doi:10.1001/jama.280.21.1831 · Cited by 1,533
Serlin, R. C., Mendoza, T. R., Nakamura, Y., Edwards, K. R., & Cleeland, C. S. (1995) · Pain · doi:10.1016/0304-3959(94)00178-h · Cited by 1,494
Rowbotham, M. (1998) · JAMA · doi:10.1001/jama.280.21.1837 · Cited by 1,433
Advances in Neuropathic Pain: Diagnosis, Mechanisms, and Treatment Recommendations
Dworkin, R. H., Backonja, M., Rowbotham, M. C., Allen, R. R., Argoff, C. R., Bennett, G. J., Bushnell, M. C., Farrar, J. T., Galer, B. S., Haythornthwaite, J. A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.11.1524 · Cited by 1,216
Rosenstock, J., Tuchman, M., LaMoreaux, L., & Sharma, U. (2004) · Pain · doi:10.1016/j.pain.2004.05.001 · Cited by 725
Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life
Galer, B. S., Gianas, A., & Jensen, M. P. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00112-6 · Cited by 601
Sabatowski, R., Gálvez, R., Cherry, D. A., Jacquot, F., Vincent, E., Maisonobe, P., & Versavel, M. (2004) · Pain · doi:10.1016/j.pain.2004.01.001 · Cited by 527
Nikolajsen, L., & Jensen, T. S. (2001) · British Journal of Anaesthesia · doi:10.1093/bja/87.1.107 · Cited by 493
Incidence of central post-stroke pain
Andersen, G., Vestergaard, K., Ingeman-Nielsen, M., & Jensen, T. S. (1995) · Pain · doi:10.1016/0304-3959(94)00144-4 · Cited by 465
Use of anticonvulsants for treatment of neuropathic pain
Backonja, M.-M. (2002) · Neurology · doi:10.1212/wnl.59.5_suppl_2.s14 · Cited by 430
Trigeminal neuralgia—pathophysiology, diagnosis and current treatment
Nurmikko, T. J., & Eldridge, P. R. (2001) · British Journal of Anaesthesia · doi:10.1093/bja/87.1.117 · Cited by 417
Pain and dysesthesia in patients with spinal cord injury: A postal survey
Finnerup, N., Johannesen, I., Sindrup, S., Bach, F., & Jensen, T. (2001) · Spinal Cord · doi:10.1038/sj.sc.3101161 · Cited by 300
Pharmacologic treatment of pain in polyneuropathy
Sindrup, S. H., & Jensen, T. S. (2000) · Neurology · doi:10.1212/wnl.55.7.915 · Cited by 296
An Overview of Neuropathic Pain: Syndromes, Symptoms, Signs, and Several Mechanisms
Dworkin, R. H. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200211000-00001 · Cited by 277
Peripheral neuropathic pain—a multidimensional burden for patients
Meyer‐Rosberg, K., Kvarnström, A., Kinnman, E., Gordh, T., Nordfors, L., & Kristofferson, A. (2001) · European Journal of Pain · doi:10.1053/eujp.2001.0259 · Cited by 247
Gilbert, F. J., Grant, A., Gillan, M. G., Vale, L. D., Campbell, M., SCOTT, N. W., Knight, D. J., & Wardlaw, D. (2004) · Radiology · doi:10.1148/radiol.2312030886 · Cited by 146
Pharmacological Management of Neuropathic Pain
McCleane, G. J. (2003) · CNS Drugs · doi:10.2165/00023210-200317140-00003 · Cited by 103
Use of gabapentin to reduce chronic neuropathic pain in Fabry disease
Ries, M., Mengel, E., Kutschke, G., et al. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1025127723729 · Cited by 64
Cited by
Dworkin, R. H., O'Connor, A. B., Audette, J., Baron, R., Gourlay, G. K., Haanpää, M. L., Kent, J. L., Krane, E. J., LeBel, A. A., Levy, R. M., et al. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0649 · Cited by 1,325
Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes
Hicks, C. W., & Selvin, E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1212-8 · Cited by 798
Treatment of neuropathic pain: an overview of recent guidelines.
O'Connor, A. B., & Dworkin, R. H. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.04.007 · Cited by 781
TNF-α and neuropathic pain - a review
Leung, L., & Cahill, C. M. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-27 · Cited by 630
The impact of neuropathic pain on health-related quality of life: Review and implications
Jensen, M. P., Chodroff, M. J., & Dworkin, R. H. (2007) · Neurology · doi:10.1212/01.wnl.0000259085.61898.9e · Cited by 575
Metadata
- Authors
- McDermott, A. M., Toelle, T. R., Rowbotham, D. J., Schaefer, C. P., & Dukes, E. M.
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2006-02
- Volume
- 10
- Issue
- 2
- Pages
- 127-127
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W2043299767
- Cited by
- 374
- References
- 23
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.